Can Beacon Capital Put Dorchester on Biotech Map?
The life science industry is well-known for its tendency to cluster in preferred real estate submarkets. So why would biotechs take a flier on a 65-year-old former newspaper building a 30-minute subway ride from Kendall Square?





